Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Aug 30;16(4):1773-1778.
doi: 10.21037/jgo-2025-492. Epub 2025 Aug 26.

New dosing schedules in pre-treated patients with metastatic colorectal cancer

Per Pfeiffer  1   2 , Line Schmidt Tarpgaard  1   2
Affiliations
Editorial

New dosing schedules in pre-treated patients with metastatic colorectal cancer

Per Pfeiffer et al. J Gastrointest Oncol. .
No abstract available

Keywords: Metastatic colorectal cancer (mCRC); chemo-refractory; dose adjustment; fruquintinib.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-2025-492/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Zhang Q, Niu H, Cheng K, et al. Efficacy and safety of dose adjustment for fruquintinib in the third-line treatment of metastatic colorectal cancer: a retrospective study with real-world settings. J Gastrointest Oncol 2025;16:542-8. - PMC - PubMed
    1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024;74:229-63. 10.3322/caac.21834 - DOI - PubMed
    1. Cervantes A, Adam R, Roselló S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2023;34:10-32. - PubMed
    1. Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 2016;27:1386-422. 10.1093/annonc/mdw235 - DOI - PubMed
    1. Abrams TA, Meyer G, Schrag D, et al. Chemotherapy usage patterns in a US-wide cohort of patients with metastatic colorectal cancer. J Natl Cancer Inst 2014;106:djt371 . 10.1093/jnci/djt371 - DOI - PubMed